SCHEMBL20133649

SCHEMBL20133649

COC(=O)c1cc(NC2CCN(c3c(F)cc(F)cc3C#N)CC2)c(C)cc1C

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.49
RPTOR Q8N122 4/20 0.49
MLST8 Q9BVC4 4/20 0.49
MAP3K5 Q99683 1/20 0.39
KDM4E B2RXH2 2/20 0.39
KMT2A Q03164 1/20 0.38
CHEK1 O14757 1/20 0.38
CHEK2 O96017 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GPR6 P46095 7/20 0.37
OPRK1 P41145 1/20 0.37
CHRM4 P08173 1/20 0.36
HPGD P15428 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
P2RY12 Q9H244 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20133861 0.90 MTOR (0.50) MTORRPTORMLST8MAP3K5GPR6
SCHEMBL20133636 0.88 MTOR (0.57) MTORRPTORMLST8MAP3K5KDM4E
SCHEMBL20129666 0.81 MTOR (0.62) MTORRPTORMLST8KDM4EKMT2A
SCHEMBL20133701 0.79 MTOR (0.61) MTORRPTORMLST8KDM4EKMT2A
SCHEMBL20129693 0.78 MTOR (0.61) MTORRPTORMLST8KDM4EKMT2A
SCHEMBL20133634 0.78 MTOR (0.59) MTORRPTORMLST8MAP3K5KDM4E
SCHEMBL20133562 0.77 MTOR (0.72) MTORRPTORMLST8MAP3K5KMT2A
SCHEMBL20133856 0.77 MTOR (0.56) MTORRPTORMLST8KDM4EKMT2A
SCHEMBL20133679 0.75 NOTUM (0.47) MTORRPTORMLST8KDM4ECHEK1
SCHEMBL20133548 0.75 MTOR (0.56) MTORRPTORMLST8KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2020-11-24 US disclosed
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2020-07-02 US disclosed
EP-3538091-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF Navitor Pharmaceuticals, Inc. (US) 2019-09-18 EP disclosed
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof NAVITOR PHARMACEUTICALS, INC. (US) 2019-09-17 US disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
WO-2018089499-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. (US) 2018-05-17 WO disclosed
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF NAVITOR PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10844013-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-10414727-B2 Phenyl amino piperidine mTORC inhibitors and uses thereof MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20180127370-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885
US-20200207716-A1 PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF MTOR, RICTOR, RPTOR MTOR 1/4885RPTOR 3/4885MLST8 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.